Neudle.com: Parkinson disease dementia with

Differential
(Click to cross reference)

abducens nerve paralysis

abiotrophy

abstract reasoning

accommodation

accomodation, abnormal

acoustic nerve

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

advances in neurology

adverse drug reaction

alkalosis, respiratory

alkylating agents

alpha-synuclein

altered states of consciousness

alternating hemiplegia

alternating hemiplegia of childhood

aluminum

Alzheimer's disease

Alzheimer's disease, diagnosis of

Alzheimer's disease, familial

Alzheimer's disease, misdiagnosis

Alzheimer's disease, treatment of

Alzheimer's disease, visual variant

amnesia

amnesia, concussion

amyloid angiopathy, cerebral

amyloid plaques

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, childhood

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

amyotrophic lateral sclerosis, post-encephalitic

ANA

angiography, cerebral

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

atlanto axial dislocation, congenital

atonic bladder

ATP1A3 gene

attention deficit disorder with hyperactivity

attention span

atypical

audiogram

auditory and vestibular pathways

autoantibodies

autonomic dysfunction

Babinski sign

basal ganglia, calcification of

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavior

behavioral disorder

benign essential tremor

blood dyscrasias, neurologic findings with

brain transplantation

burst suppression pattern, electroencephalogram

buspirone

cachexia

calcification, intracranial

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan, angiography

CAT scan, angiography, false negative

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, venography

cataracts

catecholamine

cavernous sinus, syndrome

cavum septi pellucidi

central hypoventilation

central nervous system, infection of

cerebellar atrophy, primary

cerebellar degeneration

cerebellar disease, eye movement disorder in

cerebellar lesion

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral autosomal recessive arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral death

cerebral glucose metabolism

cerebral infarction, subcortical

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, lactic acid concentration

cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)

cerebrospinal fluid, pressure low

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, recurrent

ceruloplasmin, serum

Charcot-Marie-Tooth

Charles Bonnet's syndrome

chemotherapy, CNS treatment and complications with

children

chlorpromazine

cholelithiasis

choline acetyltransferase

cingulate island sign

cirrhosis

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

controversies in neurology

convergence

convergence, impaired

conversion reaction

corpus callosum, lesion of

cortical-basal ganglionic degeneration

cranial neuropathy, multiple

cultured skin fibroblasts

cycad seed flour

dantrolene sodium

deep gray nuclei

degenerative diseases of CNS

dementia, age at onset

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic evaluation of

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, posttraumatic

dementia, presenile

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, subcortical

dementia, thalamic

dementia, treatment of

deprenyl

depression

depression, psychotic

desipramine

developmental milestones

developmental milestones, loss of

developmental retardation

differential diagnosis

dilantin

diplopia

disability, neurological

downward gaze, paralysis of

driving

drooling

droperidol

drug induced neurologic disorders

drug withdrawal

dural arteriovenous malformation

dysarthria

dysdiadochokinesia

dysexecutive syndrome

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, post traumatic

dystonia, treatment of

efficacy

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

encephalopathy, delayed

enolase

enzyme inhibition

epidemiology of neurology

evidence-based research

executive dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

Fabry's disease

facial nerve palsy, bilateral

fine motor function, impaired

fingerprint bodies

fistula, arterio-venous, dural

Fragile-X associated tremor/ataxia-syndrome

fragile-X syndrome

Friedreich's ataxia

frontal behavioral spatial syndrome

frontal lobe, anatomy and physiology

frontal lobe, atrophy

frontal lobe, behavior with disease of

frontal lobe, pathologic signs of

frontotemporal dementia, behavioral variant

gait disorder

gait, apraxic

gait, festinating

gamma amino butyric acid

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic testing

Gerstmann-Straussler-Scheinker disease

Gilles de la Tourette syndrome

glabellar sign

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

granulovacuolar degeneration

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination

hallucination, visual

hallucination, visual, benign

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatitis

hepatolenticular degeneration(Wilson's disease)

hepatomegaly

hepatosplenomegaly

heralding manifestation

herpes virus infection

hydrocephalus, normal pressure

hypocalcemia, causes of

hypotension, neurologic causes of

hypotension, systemic

hypotonia

iatrogenic neurologic disorders

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inattention

inborn errors of metabolism

incidence

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion bodies, location of

incontinence, fecal

infantile tremor syndrome

inflexibility, mental

insomnia

insular cortex

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracranial hypotension

Isaacs syndrome

isoniazid

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, variant

Kayser-Fleischer ring

kinesia paradoxica

Korsakoff's psychosis

lactic acidemia

lacunar infarction

language disorder in adults

laryngismus stridulus

L-dopa

L-dopa, drug interactions with and side effects of

leukemia, neurologic findings assoc.with

leukoencephalopathy

level of consciousness, decreased

levitation

Lewy body

Lewy body disease, diffuse

life expectancy

lipid storage disorder of CNS

lithium

liver disease

liver function enzymes

liver transplantation

lobar atrophy

locus ceruleus, lesion of

logopenia

lorazepam

loss of sympathy

lumbar puncture, complications of

lymphopenia

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

manganese intoxication

medical-legal aspects of neurology

memantine

memory

memory enhancement

memory, defect of recent

memory, impairment of

meningismus

meningitis

meningitis, carcinomatous

meningoencephalopathy

methotrexate

methylhydrazine derivatives

MHPG

microangiopathy, brain

microcephaly

micrographia

microhemorrhage, intracerebral

mild cognitive impairment

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

motor neuron disease, juvenile form

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

MRI, angiography, false negative

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, diffusion weighted

MRI, susceptibility weighted

MRI, venography

multiple sclerosis

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

myasthenic syndrome, treatment of

myoclonus, stimulus sensitive

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-treatment of

nerve growth factor

neurofibrillary degeneration

neuroleptic

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, systemic cancer

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic evaluation

neuron specific enolase

neuronal ceroid-lipofuscinosis

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

next-generation sequencing

nucleus basalis of Meynert

nystagmus

nystagmus, monocular

nystagmus, rotary

obsessive-compulsive disorder

ocular motility, disorders of

oculogyric crisis

olanzapine

old age, neurology of

opened mouth

ophthalmoplegia

ophthalmoplegia, painful

ophthalmoplegia, total

optic atrophy

optokinetic nystagmus, abnormal

orthostatic hypotension

pain

pain, increased response

paraplegia, in flexion

parasomnia

paresthesias

parietal lobe, atrophy

parietal lobe, lesion of

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, motor neuron disease with

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

Parkinsonism-dementia complex

paroxysmal hemiplegia

paroxysmal neurologic deficits

pathologic reflex

pathology

peduncular hallucinosis

penguin silhouette sign

penicillamine

peptides, brain

perceptual-motor dysfunction

pergolide

periodic paralysis

periodic paralysis, thyrotoxic

pleocytosis of cerebrospinal fluid

POLG1 gene

posterior cortical atrophy

posterior leukoencephalopathy syndrome

postural abnormality

practice guidelines

precipitating factors

premarin

prevention of neurologic disorders

primary intracranial hypotension

progressive neurologic disorder

progressive supranuclear palsy

protein 14-3-3, cerebrospinal fluid

protein 14-3-3, cerebrospinal fluid, false negative

proteinopathy

pseudobulbar palsy

pseudoxanthoma elasticum

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

psychosomatic disease

pure autonomic failure

pursuit eye movements, abnormal

putamen, lesion of

putamen, lesion of, bilateral

pyramidal tract dysfunction

pyruvate metabolism, abnormality of

radiation therapy, CNS treatment and complications with

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

recurrent

reflex sympathetic dystrophy

release phenomena

REM sleep

REM sleep behavior disorder

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

saccadic eye movements, abnormal

safety

sagging of the brain

salivation, excessive

schizophrenia

seborrheic dermatitis

seizure, treatment of

seizure, treatment of, first

selective serotonin reuptake inhibitors

senile plaques

sensorineural hearing loss

sensory loss

sensory loss, cortical

sequencing difficulty

sexual dysfunction in neurologic disease

shoulder, pain in

sinemet

single photon emission computed tomography

skin, biopsy

sleep

sleep apnea

sleep apnea, obstructive

sleep pathology and physiology

slow virus infection of CNS

small vessel disease

small vessel disease, cerebral

smell

Smell Identification Test

SNCA duplication

snoring

sodium-glucoe cotransporter-2 inhibitors

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

splenomegaly

spongy degeneration of brain

sports medicine, neurology of

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stooped posture

striatonigral degeneration

striatonigral degeneration, infantile

stridor

striopallidodentate calcifications, familial idiopathic

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subcortical U fibers

subdural hematoma

subdural hematoma, acute

sweating, abnormality of

syncope

synucleinopathy

syphilis, diagnosis and treatment

syphilis, neurologic complications with

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, atrophy

tetany

tetany, latent

tetany, normocalcemic

thalamus, lesion of

thalamus, lesion of-bilateral

torticollis, post traumatic

trauma

trazodone

treatment of neurologic disorder

tremor

tremor, intention

tremor, jaw

tremor, post traumatic

tremor, resting

tremor, thalamic stimulation for suppression of

tremor, treatment of

tremor, wing beating

tricyclic antidepressant

trinucleotide repeats

urine test for metabolic disorders

vertigo, treatment of

vinblastine

vincristine neurotoxicity

viral infection, CNS

vision, blurred

vision, failure of in childhood

visual acuity, decreased

visual impairment

visual loss

visual loss, progressive

visual loss, slow

visual symptoms

visuospatial disturbance

vitamin E

vocal cord paralysis

voice, abnormality of

von Bonsdorff's sign

walking, difficulty with

weight loss

wheelchair

white matter disease

white matter disease, subcortical

wide based gait

word-finding difficulty

wrist drop

Showing articles 750 to 800 of 3566 << Previous Next >>

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Age, Neuropathology, and Dementia
NEJM 360:2302-2309, Savva,G.M.,et al, 2009

Clinicopath Conf, Neuro-Behcets Disease
NEJM 360:2341-2351, Case 17-2009, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

Association Between Mid-Life Martial Status and Cognitive Function in Later Life: Population Based Cohort Study
BMJ 339:99,57, H�kansson,K.,et al, 2009

Disclosure of APOE Genotype for Risk of Alzheimers Disease
NEJM 361:245-254,298, Green,R.C.,et al, 2009

Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease
J Neuro-Ophthalmol 29:149-150, Finelli,P.F., 2009

MRI Lesion Profiles in Sporadic Creutzfeldt-Jakob Disease
Neurol 72:1994-2001, Meissner,B.,et al, 2009

Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009

Seizures in Alzheimer Disease: Who, When, and How Common?
Arch Neurol 66:992-997, Scarmeas,N.,et al, 2009

A 75-Year-Old Woman with Progressive Right-Hand Tremor and Inability to Use Her Right Side
Neurol 73:1399-1405, Kertesz,A.,et al, 2009

Deep Brain Stimulation for Tourette Syndrome
Neurol 73:e87-e90, Black,K., 2009

Thalmic Deep Brain Stimulation for Treatment-Refractory Tourette Syndrome
Neurol 73:1375-1380,e87, Porta,M.,et al, 2009

Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009

The Clinical Course of Advanced Dementia
NEJM 361:1529-1538, 1595, Mitchell,S.,et al, 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Diagnosis and Therapy in Neuromuscular Disorders: Diagnosis and New Treatments in Mitochondrial Diseases
JNNP 80:943-953, Rahman,S. &Hanna,M.G., 2009

Multiple Sclerosis with Predominant, Severe Cognitive Impairment
Arch Neurol 66:1139-1143, Staff,N.,et al, 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

Akinetopsia in the Posterior Cortical Variant of Alzheimer Disease
Neurol 73:731-732, Tsai,P. &Mendez,M.F., 2009

DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009

Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
JAMA 302:2565-2572, 2593, Lieb,W.,et al, 2009

Road Safety in Drivers With Parkinson Disease
Neurol 73:2112-2119, Uc,E.,et al, 2009

Association of Parental Dementia With Cognitive and Brain MRI Measures in Middle-Aged Adults
Neurol 73:2071-2078, 2054, Debette,S.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

Imaging-Pathologic Correlation in Corticobasal Degeneration
AJNR 30:1884-1892, Tokumaru,A.,et al, 2009

Clinical Syndromes Associated with Posterior Atrophy: Early Age at Onset AD Spectrum
Neurol 73:1571-1578, Migliaccio,R.,et al, 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

Predicting the Time of Conversion to MCI in the Elderly: Role of Verbal Expression and Learning
Neurol 73:1436-1442, 1432, Oulhaj,A.,et al, 2009

Rhinorrhea and Olfaction in Parkinson Disease
Neurol 70:487-489, Friedman, J.H.,et al, 2008

Deep Brain Stimulation in 18 Patients With Severe Gilles de la Tourette Syndrome Refractory to Treatment: The Surgery and Stimulation
JNNP 79:136-142,111, Servello,D.,et al, 2008

Survival Times in People with Dementia: Analysis From Population Based Cohort Study With 14 Year Follow-Up
BMJ 336:258-262,225, Xie,J.,et al, 2008

Stereotactic Radiosurgery for Treatment of Epilepsy
Arch Neurol 65:177-183, Quigg,M. &Barbaro,N.M., 2008

Prevalence of Cerebral Microhemorrhages in Amateur Boxers as Detected by 3T MR Imaging
AJNR 29:388-391, H�hnel,S.,et al, 2008

Psychogenic Tremor Occurring After Deep Brain Stimulation Surgery for Essential Tremor
Neurol 70:1498-1499, McKeon,A.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

Systematic Review of Therapeutic Intervention in Human Prion Disease
Neurol 70:1272-1281, Stewart,L.A.,et al, 2008

A longitudinal Study of Drivers With Alzheimer Disease
Neurol 70:1171-1178, Ott, B.R.,et al, 2008

Invited Article: Nervous System Pathology in Sporadic Parkinson Disease
Neurol 70:1916-1925, Braak,H. & Del Tredici,K., 2008

A Randomized Placebo-Controlled Trial of Ginkgo Biloba for the Prevention of Cognitive Decline
Neurol 70:1807-1817,1730, Dodge,H.H.,et al, 2008

Reversible Parkinsonism and Ataxia Associated With High-Dose Octreotide
Neurol 70:2345-2346, Espay,A.J., 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Biochemical Markers in Persons With Preclinical Familial Alzheimer Disease
Neurol 71:85-92,78, Ringman,J.M.,et al., 2008

Showing articles 750 to 800 of 3566 << Previous Next >>